Baxter International (BAX)
(Delayed Data from NYSE)
$33.45 USD
-0.07 (-0.21%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $33.45 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum A VGM
Brokerage Reports
Baxter International Inc. [BAX]
Reports for Purchase
Showing records 161 - 180 ( 509 total )
Company: Baxter International Inc.
Industry: Medical - Products
Comprehensive Technical and Fundamental Analysis for BAX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Baxter International Inc.
Industry: Medical - Products
Comprehensive Technical and Fundamental Analysis for BAX.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Baxter International Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Baxter International Inc.
Industry: Medical - Products
MedTech 2022 Outlook An Early Dodgeball Story
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Baxter International Inc.
Industry: Medical - Products
Company: Baxter International Inc.
Industry: Medical - Products
Company: Baxter International Inc.
Industry: Medical - Products
Company: Baxter International Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Baxter International Inc.
Industry: Medical - Products
Company: Baxter International Inc.
Industry: Medical - Products
Company: Baxter International Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Baxter International Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Baxter International Inc.
Industry: Medical - Products
Company: Baxter International Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Baxter International Inc.
Industry: Medical - Products
Company: Baxter International Inc.
Industry: Medical - Products
Remain Focused on LT Opportunity for the Combined BAX/HRC Portfolio
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Baxter International Inc.
Industry: Medical - Products
Relatively Stable Quarter Likely a Positive
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Baxter International Inc.
Industry: Medical - Products
Company: Baxter International Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department